Single Patient Study of JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease
Latest Information Update: 23 Apr 2025
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Malignant-atrophic-papulosis
- Focus Therapeutic Use
Most Recent Events
- 16 Apr 2025 Status changed from active, no longer recruiting to completed.
- 16 Dec 2024 Status changed from recruiting to active, no longer recruiting.
- 27 Mar 2024 Planned End Date changed from 15 Mar 2024 to 15 Mar 2025.